AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment.

The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump’s “most ...

Anabolic steroids can cause serious health risks, including heart attacks, strokes, reduced fertility, hardening of the arteries, liver damage, the development of male characteristics in women (such ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

Amgen and eight other pharma giants struck deals with the Trump administration to cut U.S. drug prices while gaining tariff relief and manufacturing incentives.

New Jersey-based pharma companies joined White House drug pricing deals aimed at lowering prescription drug costs under Trump’s policy.

Friday’s announcement is the latest in a series of events in which Trump has boasted of securing cooperation from drug makers ...

Drugmaker GSK has struck an agreement with the US to cut the cost of prescription medicines for American patients, including ...

GSK inks agreement with US govt to lower drug prices and expand access to respiratory medicines for millions of Americans: London, UK Monday, December 22, 2025, 09:00 Hrs [IST] GS ...

GSK has struck a voluntary agreement with the US government to lower the cost of prescription medicines, and expand access to ...

Prescription drug prices for Americans could drop sharply after President Donald J. Trump announced nine new agreements with major pharmaceutical companies to bring U.S. prices in line with the lowest ...

On May 12, 2025, President Trump signed an Executive Order titled: "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" directing the Administration to take numerous actions ...